sponsored topics see a problem let us know legal help apvo stock price  aptevo therapeutics inc stock quote us nasdaq  marketwatch sections watchlist signup • login search bulletin us europe asia fx rates futures range d d m m m y y dow    sp     nasdaq    globaldow    gold    oil    sp  movers fcx  nem  rrc  cat  stx  ipg  mu  wat  latest newsall times eastern a updated brits don’t want america’s chlorinated chickens in their supermarkets a updated  stocks for betting on the rush away from cash a updated here’s why oil just scored its biggest oneday rally of  a nintendo holds to switch sales view despite demand a petrofac wins  million in contracts in iraq a gkn earnings rise offers upbeat  outlook a french consumer confidence drops sharply a tullow oil swings to loss on impairment a updated itv rises  after dividend hike a germanys dax opens  point lower at  to be replaced home investing quotes stocks united states apvo overview compare quotes stock screener earnings calendar sectors nasdaq apvo us nasdaq join td ameritrade find a broker aptevo therapeutics inc watchlist createapvoalert closed last updated jul    pm edt delayed quote     previous close  advanced charting d d m m m ytd y y all   vol advanced charting  vs avg volume k  day avg  k open  close   day lowhigh  day range   week lowhigh  your watchlist customize marketwatch have watchlists log in to see them here or sign up to get started create account … or log in symbol last chg chg  no items in watchlist there are currently no items in this watchlist add ticker to watchlist go to your watchlist no saved watchlists create a list of the investments you want to track create watchlist …or try this starter list uh oh something went wrong while loading watchlist go to watchlist recently viewed tickers no recent tickers visit a quote page and your recently viewed tickers will be displayed here search tickers overview profile news charts financials historical quotes analyst estimates options sec filings insiders key data open  day range     week range    market cap m shares outstanding m public float m beta  rev per employee k pe ratio na eps  yield na dividend na exdividend date na short interest k   of float shorted  average volume k performance  day   month   month  ytd   year  recent news marketwatch other dow jones no headlines available no headlines available recent news other news press releases aptevo therapeutics apvo investor presentation  slideshow aptevo therapeutics apvo investor presentation  slideshow jun   at  am et on seeking alpha new dogs for old tricks new dogs for old tricks jun   at  am et on seeking alpha biotech has a promising future biotech has a promising future may   at  am et on gurufocuscom emergent biosolutions a very attractive riskreward biodefense play emergent biosolutions a very attractive riskreward biodefense play may   at  am et on seeking alpha provident investment management inc buys gentex corp bioverativ inc aptevo therapeutics  provident investment management inc buys gentex corp bioverativ inc aptevo therapeutics inc sells carmax inc zeltiq aesthetics inc t rowe price group inc may   at  pm et on gurufocuscom q aptevo therapeutics inc q aptevo therapeutics inc may   at  pm et on edgar online  edg  q k emergent biosolutions inc moves things around still sees growth may   at  pm et on motley fool k aptevo therapeutics inc mar   at  am et on edgar online  edg  q k emergent biosolutions inc sets its goal feb   at  pm et on motley fool emergent down on  view posts preliminary  results jan   at  pm et on zackscom hottest manufacturing stocks now – glf adhd fbio cris dec   at  pm et on investorplacecom biggest movers in manufacturing stocks now – evok apvo elgx hznp dec   at  am et on investorplacecom a realistic look at aptevo nov   at  pm et on seeking alpha q aptevo therapeutics inc nov   at  pm et on edgar online  edg  q k emergent biosolutions inc slimmed down waiting on contract nov   at  pm et on motley fool emergent ebs beats earnings  revenue estimates in q nov   at  am et on zackscom biggest movers in manufacturing stocks now – mtl beav rxn bcrx oct   at  am et on investorplacecom biggest movers in manufacturing stocks now – crbp chma crmd nby oct   at  am et on investorplacecom aptevo an orphaned spinoff oct   at  am et on seeking alpha biggest movers in manufacturing stocks now – spu cccl cfrx athx sep   at  am et on investorplacecom aptevo therapeutics and alligator bioscience announce plans to codevelop novel bispecific antibody for tumordirected immunotherapy aptevo therapeutics and alligator bioscience announce plans to codevelop novel bispecific antibody for tumordirected immunotherapy jul   at  pm et on globenewswire aptevo therapeutics highlights key features of its adaptirtm protein therapeutic platform at two industry conferences aptevo therapeutics highlights key features of its adaptirtm protein therapeutic platform at two industry conferences jun   at  am et on globenewswire aptevo therapeutics reports first quarter  financial results aptevo therapeutics reports first quarter  financial results may   at  am et on globenewswire aptevo therapeutics presents detailed overview of its adaptirtm protein therapeutic platform at the th annual pegs summit aptevo therapeutics presents detailed overview of its adaptirtm protein therapeutic platform at the th annual pegs summit may   at  am et on globenewswire aptevo therapeutics presents new clinical data evaluating the safety and efficacy of ixinity in children with hemophilia b apr   at  am et on globenewswire aptevo therapeutics next generation adaptirtm bispecific antibody candidates show potent immune activation apr   at  am et on globenewswire aptevo therapeutics reports  financial results and provides business update mar   at  am et on globenewswire aptevo therapeutics announces new ixinity supply available may  mar   at  am et on globenewswire aptevo therapeutics expands bispecific antibody portfolio mar   at  am et on globenewswire aptevo therapeutics to present at the th annual roth conference mar   at  am et on globenewswire aptevo therapeutics receives  million payment from emergent biosolutions jan   at  am et on globenewswire aptevo therapeutics presents data on its adaptirtm antibody platform at the th annual peptalk conference jan   at  am et on globenewswire aptevo therapeutics resumes ixinity manufacturing anticipates reentering the market in the second quarter of  jan   at  am et on globenewswire aptevo therapeutics announces publication of phase  clinical data for otlertuzumab dec   at  am et on globenewswire aptevo therapeutics amends collaboration agreement with morphosys ag for novel immunotherapeutic mores dec   at  pm et on globenewswire aptevo therapeutics to present at the th annual piper jaffray healthcare conference nov   at  am et on globenewswire aptevo therapeutics augments leadership team sep   at  am et on globenewswire emergent biosolutions announces conversion rate adjustment to  convertible senior notes due  following spinoff of aptevo therapeutics aug   at  pm et on globenewswire aptevo therapeutics closes  million term loan agreement aug   at  am et on businesswire  bzx aptevo therapeutics secures  million term loan agreement aug   at  am et on businesswire  bzx aptevo therapeutics inc aptevo therapeutics inc focuses on novel oncology and hematology therapeutics to meaningfully improve patients lives it also products in the areas of hematology and infectious diseases as well as various investigational stage product candidates in immuneoncology aptevo therapeutics was founded on february   and is headquartered in seattle wa see full profile analyst ratings sell under hold over buy number of ratings  full ratings benzingas top initiations sep   at  am et on benzingacom competitors name chg  market cap pdl biopharma inc  m plandai biotechnology inc  m bioblast pharma ltd  m pieris pharmaceuticals inc  m competitor data provided by partner content trending tickers powered by amd  ntdoy  x  t  irbt  advanced search stocks columns authors topics no results found video center learn morestoryful a division of news corp which owns marketwatch is a leading social media services company headquartered in dublin ireland storyful combines world class journalism with industryleading technology to discover verify and acquire original content and provide the ontheground sources news and media organizations need to tell the stories that matter to their audience stocks index  markets index bulletin investor alert new york markets open in market snapshot analyst ratings stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies browse stocks stocks az abcdefghijklmnopqrstuvwxyzother browse by location argentina australia austria bahamas bahrain belgium bermuda botswana brazil british virgin islands canada cayman islands chile china colombia curacao cyprus czech republic denmark egypt estonia finland france germany gibraltar greece hong kong hungary iceland india indonesia ireland isle of man israel italy japan jordan kazakhstan kuwait latvia lebanon liechtenstein lithuania luxembourg malaysia malta mauritius mexico monaco money rates morocco namibia netherlands new zealand norway oman pakistan panama peru philippines poland portugal qatar romania russia saudi arabia singapore slovakia slovenia south africa south korea spain sri lanka sweden switzerland taiwan thailand tunisia turkey ukraine united arab emirates united states venezuela western samoa log in  am edt july   marketstatecountryus new york pre marketstatecountryuk london open marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest abrits don’t want america’s chlorinated chickens in their supermarkets a stocks for betting on the rush away from cash ahere’s why oil just scored its biggest oneday rally of  anintendo holds to switch sales view despite demand apetrofac wins  million in contracts in iraq agkn earnings rise offers upbeat  outlook afrench consumer confidence drops sharply atullow oil swings to loss on impairment aitv rises  after dividend hike agermanys dax opens  point lower at  afrances cac  opens  higher at  auks ftse  opens  higher at  astoxx europe  opens  higher at  aantofagasta gold copper production rises athree ways draghi could burn the euro bulls afresnillo gold silver production rises aitv profit falls  but dividend is raised ahow china not trump trade is now lifting copper aaustralian inflation more muted than seen akpn on track to achieve targets as profit rises loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  stocks index  markets index bulletin investor alert new york markets open in market snapshot analyst ratings stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies browse stocks stocks az abcdefghijklmnopqrstuvwxyzother browse by location argentina australia austria bahamas bahrain belgium bermuda botswana brazil british virgin islands canada cayman islands chile china colombia curacao cyprus czech republic denmark egypt estonia finland france germany gibraltar greece hong kong hungary iceland india indonesia ireland isle of man israel italy japan jordan kazakhstan kuwait latvia lebanon liechtenstein lithuania luxembourg malaysia malta mauritius mexico monaco money rates morocco namibia netherlands new zealand norway oman pakistan panama peru philippines poland portugal qatar romania russia saudi arabia singapore slovakia slovenia south africa south korea spain sri lanka sweden switzerland taiwan thailand tunisia turkey ukraine united arab emirates united states venezuela western samoa log in  am edt july   marketstatecountryus new york pre marketstatecountryuk london open marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest abrits don’t want america’s chlorinated chickens in their supermarkets a stocks for betting on the rush away from cash ahere’s why oil just scored its biggest oneday rally of  anintendo holds to switch sales view despite demand apetrofac wins  million in contracts in iraq agkn earnings rise offers upbeat  outlook afrench consumer confidence drops sharply atullow oil swings to loss on impairment aitv rises  after dividend hike agermanys dax opens  point lower at  afrances cac  opens  higher at  auks ftse  opens  higher at  astoxx europe  opens  higher at  aantofagasta gold copper production rises athree ways draghi could burn the euro bulls afresnillo gold silver production rises aitv profit falls  but dividend is raised ahow china not trump trade is now lifting copper aaustralian inflation more muted than seen akpn on track to achieve targets as profit rises loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  stockscountryunited states index  markets index bulletin investor alert new york markets open in market snapshot analyst ratings stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies location united states name exchange sector  communique laboratory inc ocqlf ootc software  property insurance holdings inc pih xnas nonlife insurance flowerscom inc cl a flws xnas specialty retail pm industries inc opmz ootc food products st capital bank ca fisb ootc banking st constitution bancorp fccy xnas banking st nrg corp fnrc ootc oil extraction st source corp srce xnas banking  motors inc etfm ootc automobiles st century fox inc cl a foxa xnas broadcasting st century fox inc cl b fox xnas broadcasting vianet group inc adr vnet xnas internetonline nd century group inc xxii xase biotechnology  kid doc inc tvmd ootc healthcare provision u inc twou xnas software xleveraged long etracs linked to wells fargo business development co index  bdcl arcx major international banks xleveraged long etracs wells fargo business development lbdc arcx major international banks d eye solutions inc tdey ootc motion picturesound recording d pioneer systems inc dpsm ootc software d systems corp ddd xnys computersconsumer electronics dicon corp tdcp ootc software dshoppingcom thds ootc mixed retailing dx industries inc dddx ootc computersconsumer electronics i group plc adr tgopy ootc finance companies m co mmm xnys diversified holding companies pea international inc tpnl xotc accounting power energy group inc pspw ootc renewable energy generation tl technologies corp ttmzf ootc advertisingmarketingpublic relations  property management inc ftpm ootc real estate agentsbrokers cable tv international inc catv ootc diversified business services licensing corp fourq ootc diversified business services com ltd adr wbai xnys gambling industries job inc adr jobs xnas employmenttraining services com inc adr wuba xnys consumer services barz international inc barz ootc networking n plus inc fplsf ootc commodity chemicals d global technologies inc sixd ootc computer services  renewable energy corp rnwr ootc multiutilities  energy ltd adr tngry ootc oil extraction  holdings plc eihdf ootc gambling industries point energy partners lp cafd xnas renewable energy generation x inc eght xnas wired telecommunications services a clean slate inc drwn ootc diversified business services aw revenue royalties income fund awrrf ootc restaurants a h belo corp series a ahc xnys publishing a schulman inc shlm xnas commodity chemicals a schulman inc  pfd slmnp ootc commodity chemicals ad makepeace co make ootc farming am castle  co cas xnys wholesalers ao smith corp aos xnys building materialsproducts ap moellermaersk as adr amkby ootc water transportshipping ap moellermaersk as series a amkaf ootc water transportshipping ap moellermaersk as series b amkbf ootc water transportshipping as roma spa asraf ootc recreational services a group inc awon ootc tobacco a networks inc aten xnys computer services a milk co ltd acopf ootc biotechnology aac holdings inc aac xnys healthcare provision aac technologies holdings inc aacaf ootc industrial electronics aac technologies holdings inc adr aacay ootc industrial electronics aaon inc aaon xnas building materialsproducts aap inc aapj ootc food products aar corp air xnys aerospace productsparts aarons inc aan xnys consumer services ab science sa abscf ootc pharmaceuticals ab svensk exportkredit elements linked to mlcx biofuels index total return fue arcx finance companies ab svensk exportkredit elements linked to mlcx grain index total return gru arcx finance companies abt financial corp abto ootc banking abacus mining  exploration corp abcff ootc general mining abakan inc abki ootc industrial products abattis bioceuticals corp attbf ootc biotechnology abaxis inc abax xnas medical equipmentsupplies abb ltd ablzf ootc industrial machinery abb ltd adr abb xnys industrial machinery abbott laboratories abt xnys pharmaceuticals abbvie inc abbv xnys biotechnology abby inc abby ootc oil extraction abcam plc abczf ootc biotechnology abcam plc adr abczy ootc biotechnology abco energy inc abce ootc industrial machinery abcourt mines inc abmbf ootc general mining aben resources ltd abnaf ootc general mining abengoa sa b agoaf ootc construction abeona therapeutics inc abeo xnas biotechnology abeona therapeutics inc wt abeow xnas abercrombie  fitch co anf xnys clothing retail aberdeen asiapacific income fund inc fax xase closedend funds aberdeen asiapacific income investment co ltd abakf ootc closedend funds aberdeen asset management plc abdnf ootc investment advisors aberdeen asset management plc adr abdny ootc investment advisors aberdeen australia equity fund inc iaf xase closedend funds aberdeen chile fund inc ch xase closedend funds aberdeen emerging markets smaller company opportunities fund inc abe xase closedend funds aberdeen global income fund inc fco xase closedend funds aberdeen greater china fund inc gch xnys closedend funds aberdeen indonesia fund inc if xase closedend funds aberdeen international inc aabvf ootc general mining aberdeen israel fund inc isl xase closedend funds aberdeen japan equity fund inc jeq xnys closedend funds aberdeen latin america equity fund inc laq xase closedend funds aberdeen singapore fund inc sgf xnys closedend funds abertis infraestructuras sa adr abrty ootc transportation services ability inc abil xnas precision products ability inc wt abiwf ootc abiomed inc abmd xnas medical equipmentsupplies abitibi royalties inc atbyf ootc general mining able energy inc able ootc gas utilities ablynx nv ablyf ootc biotechnology abm industries inc abm xnys diversified business services abraxas petroleum corp axas xnas oil extraction absecon bancorp ascn ootc banking absolute health  fitness inc ahfi ootc recreational services absolute software corp alswf ootc software abt holdings inc abot ootc precious metals abtech holdings inc abhd ootc industrial machinery abv consulting inc abvn ootc advertisingmarketingpublic relations ac immune sa aciu xnas biotechnology acacia communications inc acia xnas networking acacia diversified holdings inc acca ootc specialty retail acacia mining plc abglf ootc gold acacia research corp  acacia technologies actg xnas diversified business services acadia healthcare co inc achc xnas healthcare provision acadia pharmaceuticals inc acad xnas biotechnology acadia realty trust akr xnys acadian timber corp acazf ootc forestry  wood products acasti pharma inc acst xnas pharmaceuticals accelera innovations inc acnv ootc healthcare provision accelerate diagnostics inc axdx xnas biotechnology accelerize inc aclz xotc life insurance acceleron pharma inc xlrn xnas biotechnology accenture plc cl a acn xnys diversified business services access national corp ancx xnas banking access power inc accr ootc wired telecommunications services access worldwide communications inc awwc ootc advertisingmarketingpublic relations acciona sa acxif ootc construction acco brands corp acco xnys nondurable household products accor sa acrff ootc hotels accor sa adr accyy ootc hotels accordia golf co ltd acgff ootc recreational services accredited mortgage loan reit trust  perp cum pfd series a ahhap ootc mortgages accretive health inc achi ootc healthcare provision accuray inc aray xnas medical equipmentsupplies accuride corp acw xnys auto  commercial vehicle parts acelrx pharmaceuticals inc acrx xnas pharmaceuticals acer inc gdr reg s aceyy ootc computersconsumer electronics acerus pharmaceuticals corp trlpf ootc biotechnology aceto corp acet xnas specialty chemicals achaogen inc akao xnas biotechnology achillion pharmaceuticals inc achn xnas biotechnology aci worldwide inc aciw xnas software «» log in  am edt july   marketstatecountryus new york pre marketstatecountryuk london open marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest abrits don’t want america’s chlorinated chickens in their supermarkets a stocks for betting on the rush away from cash ahere’s why oil just scored its biggest oneday rally of  anintendo holds to switch sales view despite demand apetrofac wins  million in contracts in iraq agkn earnings rise offers upbeat  outlook afrench consumer confidence drops sharply atullow oil swings to loss on impairment aitv rises  after dividend hike agermanys dax opens  point lower at  afrances cac  opens  higher at  auks ftse  opens  higher at  astoxx europe  opens  higher at  aantofagasta gold copper production rises athree ways draghi could burn the euro bulls afresnillo gold silver production rises aitv profit falls  but dividend is raised ahow china not trump trade is now lifting copper aaustralian inflation more muted than seen akpn on track to achieve targets as profit rises loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  apvo stock price  aptevo therapeutics inc stock quote us nasdaq  marketwatch sections watchlist signup • login search bulletin us europe asia fx rates futures range d d m m m y y dow    sp     nasdaq    globaldow    gold    oil    sp  movers fcx  nem  rrc  cat  stx  ipg  mu  wat  latest newsall times eastern a updated brits don’t want america’s chlorinated chickens in their supermarkets a updated  stocks for betting on the rush away from cash a updated here’s why oil just scored its biggest oneday rally of  a nintendo holds to switch sales view despite demand a petrofac wins  million in contracts in iraq a gkn earnings rise offers upbeat  outlook a french consumer confidence drops sharply a tullow oil swings to loss on impairment a updated itv rises  after dividend hike a germanys dax opens  point lower at  to be replaced home investing quotes stocks united states apvo overview compare quotes stock screener earnings calendar sectors nasdaq apvo us nasdaq join td ameritrade find a broker aptevo therapeutics inc watchlist createapvoalert closed last updated jul    pm edt delayed quote     previous close  advanced charting d d m m m ytd y y all   vol advanced charting  vs avg volume k  day avg  k open  close   day lowhigh  day range   week lowhigh  your watchlist customize marketwatch have watchlists log in to see them here or sign up to get started create account … or log in symbol last chg chg  no items in watchlist there are currently no items in this watchlist add ticker to watchlist go to your watchlist no saved watchlists create a list of the investments you want to track create watchlist …or try this starter list uh oh something went wrong while loading watchlist go to watchlist recently viewed tickers no recent tickers visit a quote page and your recently viewed tickers will be displayed here search tickers overview profile news charts financials historical quotes analyst estimates options sec filings insiders key data open  day range     week range    market cap m shares outstanding m public float m beta  rev per employee k pe ratio na eps  yield na dividend na exdividend date na short interest k   of float shorted  average volume k performance  day   month   month  ytd   year  recent news marketwatch other dow jones no headlines available no headlines available recent news other news press releases aptevo therapeutics apvo investor presentation  slideshow aptevo therapeutics apvo investor presentation  slideshow jun   at  am et on seeking alpha new dogs for old tricks new dogs for old tricks jun   at  am et on seeking alpha biotech has a promising future biotech has a promising future may   at  am et on gurufocuscom emergent biosolutions a very attractive riskreward biodefense play emergent biosolutions a very attractive riskreward biodefense play may   at  am et on seeking alpha provident investment management inc buys gentex corp bioverativ inc aptevo therapeutics  provident investment management inc buys gentex corp bioverativ inc aptevo therapeutics inc sells carmax inc zeltiq aesthetics inc t rowe price group inc may   at  pm et on gurufocuscom q aptevo therapeutics inc q aptevo therapeutics inc may   at  pm et on edgar online  edg  q k emergent biosolutions inc moves things around still sees growth may   at  pm et on motley fool k aptevo therapeutics inc mar   at  am et on edgar online  edg  q k emergent biosolutions inc sets its goal feb   at  pm et on motley fool emergent down on  view posts preliminary  results jan   at  pm et on zackscom hottest manufacturing stocks now – glf adhd fbio cris dec   at  pm et on investorplacecom biggest movers in manufacturing stocks now – evok apvo elgx hznp dec   at  am et on investorplacecom a realistic look at aptevo nov   at  pm et on seeking alpha q aptevo therapeutics inc nov   at  pm et on edgar online  edg  q k emergent biosolutions inc slimmed down waiting on contract nov   at  pm et on motley fool emergent ebs beats earnings  revenue estimates in q nov   at  am et on zackscom biggest movers in manufacturing stocks now – mtl beav rxn bcrx oct   at  am et on investorplacecom biggest movers in manufacturing stocks now – crbp chma crmd nby oct   at  am et on investorplacecom aptevo an orphaned spinoff oct   at  am et on seeking alpha biggest movers in manufacturing stocks now – spu cccl cfrx athx sep   at  am et on investorplacecom aptevo therapeutics and alligator bioscience announce plans to codevelop novel bispecific antibody for tumordirected immunotherapy aptevo therapeutics and alligator bioscience announce plans to codevelop novel bispecific antibody for tumordirected immunotherapy jul   at  pm et on globenewswire aptevo therapeutics highlights key features of its adaptirtm protein therapeutic platform at two industry conferences aptevo therapeutics highlights key features of its adaptirtm protein therapeutic platform at two industry conferences jun   at  am et on globenewswire aptevo therapeutics reports first quarter  financial results aptevo therapeutics reports first quarter  financial results may   at  am et on globenewswire aptevo therapeutics presents detailed overview of its adaptirtm protein therapeutic platform at the th annual pegs summit aptevo therapeutics presents detailed overview of its adaptirtm protein therapeutic platform at the th annual pegs summit may   at  am et on globenewswire aptevo therapeutics presents new clinical data evaluating the safety and efficacy of ixinity in children with hemophilia b apr   at  am et on globenewswire aptevo therapeutics next generation adaptirtm bispecific antibody candidates show potent immune activation apr   at  am et on globenewswire aptevo therapeutics reports  financial results and provides business update mar   at  am et on globenewswire aptevo therapeutics announces new ixinity supply available may  mar   at  am et on globenewswire aptevo therapeutics expands bispecific antibody portfolio mar   at  am et on globenewswire aptevo therapeutics to present at the th annual roth conference mar   at  am et on globenewswire aptevo therapeutics receives  million payment from emergent biosolutions jan   at  am et on globenewswire aptevo therapeutics presents data on its adaptirtm antibody platform at the th annual peptalk conference jan   at  am et on globenewswire aptevo therapeutics resumes ixinity manufacturing anticipates reentering the market in the second quarter of  jan   at  am et on globenewswire aptevo therapeutics announces publication of phase  clinical data for otlertuzumab dec   at  am et on globenewswire aptevo therapeutics amends collaboration agreement with morphosys ag for novel immunotherapeutic mores dec   at  pm et on globenewswire aptevo therapeutics to present at the th annual piper jaffray healthcare conference nov   at  am et on globenewswire aptevo therapeutics augments leadership team sep   at  am et on globenewswire emergent biosolutions announces conversion rate adjustment to  convertible senior notes due  following spinoff of aptevo therapeutics aug   at  pm et on globenewswire aptevo therapeutics closes  million term loan agreement aug   at  am et on businesswire  bzx aptevo therapeutics secures  million term loan agreement aug   at  am et on businesswire  bzx aptevo therapeutics inc aptevo therapeutics inc focuses on novel oncology and hematology therapeutics to meaningfully improve patients lives it also products in the areas of hematology and infectious diseases as well as various investigational stage product candidates in immuneoncology aptevo therapeutics was founded on february   and is headquartered in seattle wa see full profile analyst ratings sell under hold over buy number of ratings  full ratings benzingas top initiations sep   at  am et on benzingacom competitors name chg  market cap pdl biopharma inc  m plandai biotechnology inc  m bioblast pharma ltd  m pieris pharmaceuticals inc  m competitor data provided by partner content trending tickers powered by amd  ntdoy  x  t  irbt  advanced search stocks columns authors topics no results found video center learn morestoryful a division of news corp which owns marketwatch is a leading social media services company headquartered in dublin ireland storyful combines world class journalism with industryleading technology to discover verify and acquire original content and provide the ontheground sources news and media organizations need to tell the stories that matter to their audience aptevo therapeutics inc apvo k and q sec filings  lastkcom   aptevo therapeutics inc apvo sec filing k annual report for the fiscal year ending saturday december   lastkcomsecfilingsapvohtm earnings release k annual report k exhibits k statistics   exhibit    for immediate release     aptevo therapeutics reports  financial results and provides business update   advances multiple clinical and preclinical candidates based on the company’s novel adaptir™ protein therapeutic platform   achieves  increase in yearoveryear product sales revenue     seattle wa – march    aptevo therapeutics inc nasdaq apvo a biotechnology company focused on developing novel oncology and hematology therapeutics today reported its financial results for the year ended december   and provided an update on its commercial portfolio and pipeline programs   “following the successful completion of our spinoff from emergent biosolutions emergent aptevo commenced operations in august  as an independent company with a finelytuned agenda and focused mission to serve our patients and shareholders” said marvin l white president and chief executive officer  “the combination of our novel adaptir™ protein therapeutic platform with multiple clinical and preclinical candidate opportunities and a wellestablished commercial product portfolio makes aptevo well positioned to leverage the opportunities inherent in our commercial and rd portfolios to unlock value for shareholders”      operational highlights   commercial portfolio     • achieved  increase in yearoveryear product sales revenue   • continued to expand awareness of ixinity within the hemophilia b community following its us launch in mid   • resolved ongoing bulk drug substance manufacturing challenges and resumed routine manufacturing operations which the company believes will avert a supply interruption of ixinity   pipeline     • initiated the amendment to a phase  continuous infusion dose escalation study of mores to evaluate safety and tolerability in patients with metastatic castrationresistant prostate cancer    the following information was filed by aptevo therapeutics inc on friday march   as an k  statement which is a press release pertaining to results of operations and financial condition it may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying k annual report statement of earnings and operation as management may choose to highlight particular information in the press release sentiment analysis off   on filter by sentiment positive  negative  all filter by category financial  revenue  net sales  all watch our sentiment analysis video filter by subcategory cash flow  debt  earnings  expense  geography  income  product  shares  equity  other  all click a sentiment analysis snippet below from apvos management discussions to find these positive and negative remarks within their k annual report apvokrevenue  geographyas a result we make certain estimates and assumptions in  calculating our income tax expense deferred tax assets and deferred tax liabilities  determining any valuation allowance recorded against deferred tax assets and  evaluating the amount of unrecognized tax benefits as well as the interest and penalties related to such uncertain tax positions apvokrevenue  product revenue from contracts with customers deferral of the effective date which deferred the effective date of the new revenue standard for periods beginning after december   to december   with early adoption permitted but not earlier than the original effective date apvokfinancial  expensethese expenses consist primary of personnelrelated costs fees to professional service providers for among other things analytical testing independent monitoring or other administration of our clinical trials and obtaining and evaluating data from our clinical trials and nonclinical studies costs of contract manufacturing services for clinical trial material and costs of materials used in clinical trials and research and development apvokother  otherincrease in cash and cash equivalents apvokma  otherthis contribution included a onetime payment of  million and a working capital reimbursement for outstanding payments of  million which we received in the fourth quarter of  a noncash transfer of an intangible asset of  million and a net transfer of cash from emergent of  million apvokother  otherwhile these controls are not subject to an audit by our independent registered public accounting firm management has evaluated these controls and concluded that the material weakness has been sufficiently remediated refer to item a  controls and procedures in this form k apvokfinancial  earningsgross margin decreased due to the ongoing challenges with the manufacture of our ixinity product apvokfinancial  expensethe primary expense we incur to deliver our marketed products to our customers is manufacturing costs consisting of fixed and variable costs apvokother  otherasu  is effective for fiscal years beginning after december   including interim periods within those fiscal years apvokfinancial  expensethe historical financial statements do not necessarily include all of the expenses that would have been incurred had we been a separate standalone entity and may not necessarily reflect our results of operations financial position and cash flows had we been a standalone company during the periods presented apvokfinancial  expensefor the year ended december   selling general and administrative expenses decreased by  million or  to  million for  from  million for  apvokfinancial  expensevariable manufacturing costs consist primarily of costs for materials and personnelrelated expenses for direct and indirect manufacturing support staff contract manufacturing and filling operations and salesbased royalties apvokfinancial  expensethe expenses for our other activities which decreased were primarily related to centralized research and development activities not otherwise attributable to specific product candidates or programs apvokfinancial  expensedecrease in expense for our ixinity product candidate which was approved by the fda in april  due to a decrease in manufacturing process development activities in  and the timing of clinical trial activities apvokfinancial  expenseresearch and development expenses decreased by  million or  to  million for the year ended december   from  million for the year ended december   apvokrevenue  productrevenue generating collaborative research and development agreements may contain one or more provisions including licensing research services and milestone deliverables apvokrevenue  productthis increase was primarily related to revenue associated with ixinity which increased by  million for the year ended december   following ixinitys fda approval in the second quarter of  and an increase in unit sales of our varizig product apvokfinancial  expensefixed manufacturing costs include facilities utilities and amortization of intangible assets apvokrevenue  productachieved  increase in yearoveryear product sales revenue apvokother  otherstrengthened aptevos financial position securing an additional  million in a termloan financing with midcap financial received the first tranche  million in august  apvokother  othercapital improvements to new or existing facilities apvokfinancial  expensesince april  we have incurred approximately  million in research and development expense related to ixinity primarily for clinical trial activities approximately  million and development and qualification activities approximately  million apvokfinancial  incomein general if we determine that it is more likely than not to realize more than the recorded amounts of net deferred tax assets in the future we will reverse all or a portion of the valuation allowance established against its deferred tax assets resulting in a decrease to the provision for income taxes in the period in which the determination is made apvokother  otherthis standard is effective beginning january   with early adoption permitted apvokother  otheraccordingly the updated standard is effective for the company in the first quarter of fiscal  apvokother  otherthe provisions of this standard are effective for annual periods ending after december   and for annual and interim periods thereafter apvokrevenue  productthe credit agreement covenants require us and our subsidiaries to maintain increasing minimum net commercial product revenue for each twelvemonth period ending on the last day of each calendar quarter apvokrevenue  productrevenues from the achievement of research and development milestones if deemed substantive are recognized as revenue when the milestones are achieved and the milestone payments are due and collectible apvokrevenue  geographywe retain commercialization rights in the united states and canada with a tiered royalty obligation to morphosys ranging from midsingle digit up to  of sales apvokfinancial  incomebenefit from income taxes increased by  million or  to  million for the year ended december   from  million for the year ended december   due to the restatement of our deferred tax liability see note  restatement apvokrevenue  productincreased revenue from these two products however was offset by a decrease in revenue for hepagam b as a greater percentage of sales of this product occurred overseas where the price is lower due to contractual pricing agreements apvokma  otherin august  emergent biosolutions inc or emergent announced a plan to separate into two independent publicly traded companies one a biotechnology company focused on novel oncology and hematology therapeutics to meaningfully improve patients lives and the other a global specialty life sciences company focused on providing specialty products for civilian and military populations that address intentional and naturally emerging public health threats apvokother  otherwe expect our cash cash equivalents and investments along with the proceeds from our credit agreement will support our operations for at least  months based on current operating plans and financial forecasts apvokfinancial  expensethese research and development costs may be partially offset by costsharing arrangements with collaborative partners such as our collaboration with morphosys ag apvokfinancial  incomethe accompanying managements discussion and analysis of financial condition and results of operations gives effect to the restatement adjustments made to the previously reported consolidated financial statements that are discussed in note  in the notes to consolidated financial statements in item  of this form k additionally in part as a result of these restatements management has concluded that our deferred income tax account controls and procedures were not effective as of december   and september   following the august   spinoff resulting in a material weakness around these tax controls apvokother  otherin  we recorded impairments of approximately  million of longterm assets which consisted of  million of intangible assets and  million of goodwill apvokma  otheramounts allocated to acquired iprd are capitalized and accounted for as indefinitelived intangible assets apvokma  othernet cash provided by financing activities for the periods presented includes the net proceeds received from entering into the credit facility in august of  cash received from emergent upon the spin off and the net investment from the former parent company to support the operations of aptevo apvokfinancial  expensewe expect our research and development spending will be dependent upon such factors as the results from our clinical trials the availability of reimbursement of research and development spending the number of product candidates under development the size structure and duration of any clinical programs that we may initiate and the costs associated with manufacturing our product candidates on a largescale basis for later stage clinical trials apvokother  otheras a result the  million ixinity iprd asset was reclassified as a definitelive intangible asset and is being amortized over ten years apvokfinancial  incomesubsequent to the date of the spinoff we enhanced our deferred income tax accountrelated internal controls over financial reporting to ensure the proper determination of the effect on deferred income tax accounts from certain purchase accounting transactions prior to aptevos spinoff apvokma  otherwe determined the estimated selling price of the development services unit of accounting based on the estimated number of fulltime equivalent personnel at the contractual rate as defined in the morphosys agreement whose rates and terms approximate those of other emergent or our service related contracts and those observed generally through other collaboration negotiations apvokfinancial  expensethe scope progress results and costs of our development activities and click to view a specific section in this k report view entire k report consolidated balance sheets consolidated balance sheets parenthetical consolidated statements of operations consolidated statements of comprehensive loss consolidated statements of cash flows consolidated statement of changes in stockholders equity nature of business and significant accounting policies restatement morphosys collaboration agreement fair value measurements investments inventories property and equipment net impairment of intangible assets inprocess research and development and goodwill intangible assets net debt net loss per share equity k savings plan leases and contingencies income taxes subsequent events selected quarterly financial data unaudited nature of business and significant accounting policies policies nature of business and significant accounting policies tables restatement tables fair value measurements tables investments tables inventories tables property and equipment net tables intangible assets net tables debt tables net loss per share tables equity tables leases and contingencies tables income taxes tables selected quarterly financial data unaudited tables nature of business and significant accounting policies  additional information details nature of business and significant accounting policies  schedule of estimated useful lives of property and equipment details restatement  additional information details restatement  balance sheet impact details morphosys collaboration agreement  additional information details fair value measurements  additional information details fair value measurements  summary of financial assets measured at fair value details fair value measurements  summary of reconciliation of liabilities measured at fair value using significant unobservable inputs level  details investments  schedule of shortterm investments details inventories  schedule of inventories details inventories  additional information details property and equipment net  summary of property plant and equipment details impairment of intangible assets inprocess research and development and goodwill  additional information details intangible assets net  additional information details intangible assets net  schedule of future amortization expense details debt  additional information details debt  schedule of five year payments on debt details net loss per share  additional information details net loss per share  summary of potentially dilutive shares excluded from calculation of net loss per share details equity  additional information details equity  summary of stockbased compensation expense includes amortization of stock options and restricted stock units granted details equity  assumptions used in valuing the stock options granted under blackscholes valuation model details equity  summary of stock option activity details equity  summary of restricted stock activity details k savings plan  additional information details leases and contingencies  additional information details leases and contingencies  summary of future minimum lease payments under operating lease agreements details income taxes  summary of significant components of provisions for income taxes attributable to operations details income taxes  schedule of net deferred tax asset liability details income taxes  additional information details income taxes  schedule of reconciliation of unrecognized tax benefits details income taxes  schedule of benefit from income taxes differs from amount of taxes determined by applying us federal statuary rate to loss before benefit from income taxes details subsequent events  additional information details selected quarterly financial data unaudited  additional information details selected quarterly financial data unaudited  balance sheet impact details selected quarterly financial data unaudited  income statement impact details selected quarterly financial data unaudited  unaudited quarterly consolidated statement of operations data details selected quarterly financial data unaudited  unaudited quarterly consolidated statement of operations data parenthetical details  please wait while we load the requested k annual report if it does not load please click the link below  httpswwwlastkcomsecfilingsreportapvokhtm companies may provide additional information to their sec filings as exhibits click a link below to view an exhibit that was filed with this report exhibit   consents of experts and counsel  please wait while we load the requested exhibit if it does not load please click the link below  httpswwwlastkcomsecfilingsreportapvoexhtm exhibit   rule aada certification  please wait while we load the requested exhibit if it does not load please click the link below  httpswwwlastkcomsecfilingsreportapvoexhtm exhibit   rule aada certification  please wait while we load the requested exhibit if it does not load please click the link below  httpswwwlastkcomsecfilingsreportapvoexhtm exhibit   section  certification  please wait while we load the requested exhibit if it does not load please click the link below  httpswwwlastkcomsecfilingsreportapvoexhtm exhibit   section  certification  please wait while we load the requested exhibit if it does not load please click the link below  httpswwwlastkcomsecfilingsreportapvoexhtm form type annual number of times amended  accession number  submitted to the sec friday march   accepted by the sec friday march   period ending december  financial ratios intrinsic value financial stability companies  add apvo positive and negative sentiment analysis is available in these filings k march  x close k q k annual reportmarch  q quarterly reportmay  q quarterly reportnovember  q quarterly reportaugust  aptevo therapeutics inc    days range  to  week range  to  volume  volume avg  earnings per share  peg  short  pe ratios     na market cap m book value  ebitda m aptevo search aptevocom about us management team board of directors our technology pipeline otlertuzumab mores apvo apvo es alzheimer’s disease other candidates commercial products investors stock details news events presentations financial reports corporate governance investor faq investor contacts careers home blazing redefining the nature of biotech aptevo therapeutics is not the usual biotech company our proprietary adaptir™ modular protein technology platform the most innovative minds in the field and a culture of employee ownership empower us to advance the science of what’s next in oncology and hematology innovating exceeding empowering bing places for business bing places for business sign in using your microsoft account work account google account facebook account dont have an account create one